<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	
	>
<channel>
	<title>
	Comments on: &#8220;THE MOST EXPENSIVE PREVENTION IS ALSO CHEAPER THAN THE CHEAPEST TREATMENT&#8221; &#8211; LEGAL REGULATIONS FOR REPORTING PERFORMANCE TESTS OF A MEDICAL DEVICE FOR IN VITRO DIAGNOSTICS	</title>
	<atom:link href="https://www.kg-legal.eu/info/pharmaceutical-healthcare-life-sciences-law/the-most-expensive-prevention-is-also-cheaper-than-the-cheapest-treatment-legal-regulations-for-reporting-performance-tests-of-a-medical-device-for-in-vitro-diagnostics/feed/" rel="self" type="application/rss+xml" />
	<link>https://www.kg-legal.eu/info/pharmaceutical-healthcare-life-sciences-law/the-most-expensive-prevention-is-also-cheaper-than-the-cheapest-treatment-legal-regulations-for-reporting-performance-tests-of-a-medical-device-for-in-vitro-diagnostics/</link>
	<description>KIELTYKA GLADKOWSKI LEGAL &#124; CROSS BORDER POLISH LAW FIRM RANKED IN THE LEGAL 500 EMEA SINCE 2019</description>
	<lastBuildDate>Tue, 14 May 2024 12:32:52 +0000</lastBuildDate>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	
</channel>
</rss>
